Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcus aureus bi-component leukocidins are a family of potent exotoxins secreted by S. aureus to destroy host immune cells, particularly neutrophils and macrophages [Nature Reviews Microbiology, 2014]. These toxins consist of two distinct protein subunits, the S-component and the F-component, which work synergistically to form heptameric or octameric pores in the plasma membrane of target cells [UniProt]. By lysing leukocytes, these toxins facilitate immune evasion and promote the spread of infection [PubMed: 23913162]. They play a critical role in the pathogenesis of severe conditions such as necrotizing pneumonia and deep-seated skin infections [StatPearls]. Specific leukocidins, such as Panton-Valentine Leukocidin (PVL), target host receptors like C5aR1 to initiate pore formation [PubMed: 23913162]. Therapeutic strategies focus on neutralizing these toxins using monoclonal antibodies, such as the ASN100 cocktail, to prevent tissue damage and support the host's immune response [Journal of Infectious Diseases, 2018]. These toxins are significant targets in the development of treatments for multidrug-resistant S. aureus (MRSA) infections.
Neutralization of toxin subunits to prevent receptor binding and pore formation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus bi-component leukocidin (Luk).